Results 161 to 170 of about 4,770 (180)

Elexacaftor/ivacaftor/tezacaftor/ivacaftor/tezacaftor

Reactions Weekly, 2021
openaire   +1 more source

Elexacaftor/Ivacaftor/tezacaftor

Reactions Weekly, 2021
  +4 more sources

Elexacaftor/tezacaftor/ivacaftor outpatient desensitization

Annals of Allergy, Asthma & Immunology, 2022
Ramya Balijepally, Denise Kwong, Linda Zhu, Juanita Valdes Camacho, Anne Liu   +4 more
openaire   +2 more sources

Ivacaftor/tezacaftor

Reactions Weekly, 2020
openaire   +1 more source

Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial

American Journal of Respiratory and Critical Care Medicine, 2022
David P Nichols, Sonya L Heltshe, Scott H Donaldson   +2 more
exaly  

Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial

Lancet Respiratory Medicine,the, 2022
Sivagurunathan Sutharsan, Edward F Mckone, Damian G Downey   +2 more
exaly  

Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older – The RECOVER Trial

American Journal of Respiratory and Critical Care Medicine, 2023
Paul McNally, Edward McKone
exaly  

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Lancet, The, 2019
Edward F Mckone, Damian G Downey, Eva Van Braeckel   +2 more
exaly  

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

New England Journal of Medicine, 2017
Anne Munck, Edward F Mckone, Cornelis K Van Der Ent   +2 more
exaly  

VX-659–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles

New England Journal of Medicine, 2018
Marcus A Mall, Edward F Mckone, Dario Prais   +2 more
exaly